Why GILD? Gilead Sciences, Inc. Analysis, Price & AI Insights | Whystock
GILD
$131.65+0.81 (+0.62%)
Market ClosedLast close May 1
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.